1. Disease Areas
  2. Infection
  3. Bacterial Infection
  4. Pseudomonas Aeruginosa Infection

Pseudomonas Aeruginosa Infection

Pseudomonas aeruginosa pneumonia is a rare but severe lung infection that can present as primary pneumonia in intensive care settings without bacteremia or as bacteremic pneumonia, particularly in patients with neutropenia. It frequently affects individuals with cystic fibrosis, leading to recurrent chronic lower respiratory infections. Clinical manifestations include fever, chills, dyspnea, cyanosis, productive cough, and systemic toxicity. Radiological and pathological findings often reveal alveolar hemorrhage, necrosis, and cavity formation, all of which contribute to significant morbidity and mortality.

Pseudomonas Aeruginosa Infection (1):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-P99649
    Gremubamab 1800381-36-5
    Gremubamab (MEDI3902) is a humanized IgG1 kappa anti-PcrV/Psl monoclonal antibody. Gremubamab binds to the PA PcrV protein and Psl exopolysaccharide. Gremubamab has the potential for the research of pseudomonas aeruginosa infections.
    Gremubamab